Jun Weng

821 total citations
31 papers, 533 citations indexed

About

Jun Weng is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Jun Weng has authored 31 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Epidemiology. Recurrent topics in Jun Weng's work include Photosynthetic Processes and Mechanisms (5 papers), Mitochondrial Function and Pathology (4 papers) and Ion channel regulation and function (4 papers). Jun Weng is often cited by papers focused on Photosynthetic Processes and Mechanisms (5 papers), Mitochondrial Function and Pathology (4 papers) and Ion channel regulation and function (4 papers). Jun Weng collaborates with scholars based in China, United States and Japan. Jun Weng's co-authors include Ming Zhou, Yu Cao, Noah Moss, Yaping Pan, R. Bhosle, Chunhe Xu, Li Su, Suping Zhang, Jingxi Pan and Side Yao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Jun Weng

31 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Weng China 13 325 98 59 51 50 31 533
Manuel Gutiérrez‐Aguilar Mexico 15 477 1.5× 39 0.4× 50 0.8× 38 0.7× 37 0.7× 36 732
Shubha Gururaja Rao United States 16 444 1.4× 95 1.0× 93 1.6× 24 0.5× 61 1.2× 25 660
Francesca Di Sole United States 18 511 1.6× 39 0.4× 58 1.0× 32 0.6× 25 0.5× 32 799
Inés Raineri United States 11 409 1.3× 42 0.4× 36 0.6× 26 0.5× 44 0.9× 13 689
Robert Gealy United States 11 272 0.8× 101 1.0× 119 2.0× 26 0.5× 76 1.5× 13 525
Ashley Allshire Ireland 12 282 0.9× 86 0.9× 123 2.1× 22 0.4× 40 0.8× 23 589
C. Massart France 16 359 1.1× 114 1.2× 12 0.2× 29 0.6× 26 0.5× 44 745
Susana E. Martínez Spain 17 354 1.1× 57 0.6× 45 0.8× 28 0.5× 37 0.7× 25 757
Dustin Thomas United States 12 238 0.7× 60 0.6× 39 0.7× 41 0.8× 42 0.8× 15 607
Robert J. Zeleznikar United States 9 439 1.4× 69 0.7× 122 2.1× 35 0.7× 45 0.9× 10 659

Countries citing papers authored by Jun Weng

Since Specialization
Citations

This map shows the geographic impact of Jun Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Weng more than expected).

Fields of papers citing papers by Jun Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Weng. The network helps show where Jun Weng may publish in the future.

Co-authorship network of co-authors of Jun Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Weng. A scholar is included among the top collaborators of Jun Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Weng. Jun Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Lin, Yang Hu, Yanxia Liu, et al.. (2025). De novo design mini-binder proteins targeting the glycoproteins D to inhibit PRV replication in PK15 cells. International Journal of Biological Macromolecules. 315(Pt 1). 144403–144403. 1 indexed citations
2.
Wei, Lin, Yun You, Yang Hu, et al.. (2025). Rapid discovery of pseudorabies virus inhibitors repurposed from the antimicrobial agent ciprofloxacin. European Journal of Medicinal Chemistry. 289. 117490–117490. 1 indexed citations
3.
Shi, Hao, et al.. (2025). Acute rupture of primary hepatic angiosarcoma with Kasabach-Merritt syndrome: a rare case report and literature review. World Journal of Surgical Oncology. 23(1). 396–396. 1 indexed citations
4.
Lin, Wei, et al.. (2025). In vitro enzyme characterization and several inhibitors for monkeypox virus core protease I7L. FEMS Microbiology Letters. 372. 1 indexed citations
5.
Wei, Lin, Yang Hu, Licheng Bai, et al.. (2025). Design of the Inhibitors for Pseudorabies Virus Replication by Reinforcement Learning from HSV-1 DNA Polymerase Inhibitors. ACS Omega. 10(4). 3389–3397. 3 indexed citations
6.
Weng, Jun, Jing‐Kun Yan, Hua-Fang Sheng, et al.. (2024). Puerarin alleviates atherosclerosis via the inhibition of Prevotella copri and its trimethylamine production. Gut. 73(12). 1934–1943. 28 indexed citations
7.
Lin, Yansong, Shuo Li, Rong Guo, et al.. (2024). First-line hepatic arterial infusion chemotherapy plus lenvatinib and PD-(L)1 inhibitors versus systemic chemotherapy alone or with PD-(L)1 inhibitors in unresectable intrahepatic cholangiocarcinoma. Journal of Cancer Research and Clinical Oncology. 150(6). 309–309. 4 indexed citations
8.
Weng, Jun, Xiaoming Zhou, Pattama Wiriyasermkul, et al.. (2023). Insight into the mechanism of H + -coupled nucleobase transport. Proceedings of the National Academy of Sciences. 120(33). e2302799120–e2302799120. 7 indexed citations
10.
Feng, Lingyun, Jun Weng, Ning Wang, et al.. (2022). Extracellular Vesicles Derived from SIPA1high Breast Cancer Cells Enhance Macrophage Infiltration and Cancer Metastasis through Myosin-9. Biology. 11(4). 543–543. 10 indexed citations
11.
Weng, Jun, et al.. (2021). A novel nuclear localization region in SIPA1 determines protein nuclear distribution and epirubicin-sensitivity of breast cancer cells. International Journal of Biological Macromolecules. 180. 718–728. 8 indexed citations
13.
Wang, Ning, Jun Weng, Jing Xia, et al.. (2020). SIPA1 enhances SMAD2/3 expression to maintain stem cell features in breast cancer cells. Stem Cell Research. 49. 102099–102099. 14 indexed citations
14.
Su, Wei, Ruochen Wang, Li Wang, et al.. (2018). Identification of Two Mutations in PCDHGA4 and SLFN14 Genes in an Atrial Septal Defect Family. Current Medical Science. 38(6). 989–996. 5 indexed citations
15.
Tang, Chad, Steven I. Sherman, Jun Weng, et al.. (2017). Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement. Clinical Cancer Research. 23(6). 1414–1421. 27 indexed citations
16.
Liu, Fei, Yayun Qin, Shanshan Yu, et al.. (2017). Pathogenic mutations in retinitis pigmentosa 2 predominantly result in loss of RP2 protein stability in humans and zebrafish. Journal of Biological Chemistry. 292(15). 6225–6239. 13 indexed citations
17.
Li, Yang, Shengguang Yuan, Zhenran Wang, et al.. (2012). Embelin-induced MCF-7 breast cancer cell apoptosis and blockade of MCF-7 cells in the G2/M phase via the mitochondrial pathway. Oncology Letters. 5(3). 1005–1009. 28 indexed citations
18.
Pan, Yaping, Jun Weng, Yu Cao, R. Bhosle, & Ming Zhou. (2008). Functional Coupling between the Kv1.1 Channel and Aldoketoreductase Kvβ1. Journal of Biological Chemistry. 283(13). 8634–8642. 52 indexed citations
19.
Weng, Jun, Yu Cao, Noah Moss, & Ming Zhou. (2006). Modulation of Voltage-dependent Shaker Family Potassium Channels by an Aldo-Keto Reductase*. Journal of Biological Chemistry. 281(22). 15194–15200. 93 indexed citations
20.
Zhang, Suping, et al.. (2003). Study on the photo-generation of superoxide radicals in Photosystem II with EPR spin trapping techniques. Photosynthesis Research. 75(1). 41–48. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026